Your browser doesn't support javascript.
loading
Post COVID-19 vaccine deaths - Singapore's early experience.
Yeo, Audrey; Kuek, Benjamin; Lau, Mandy; Tan, Shi Rui; Chan, Shijia.
Afiliação
  • Yeo A; Forensic Medicine Division, Applied Sciences Group, Health Sciences Authority, Singapore. Electronic address: audrey_yeo@hsa.gov.sg.
  • Kuek B; Forensic Medicine Division, Applied Sciences Group, Health Sciences Authority, Singapore.
  • Lau M; Forensic Medicine Division, Applied Sciences Group, Health Sciences Authority, Singapore.
  • Tan SR; Forensic Medicine Division, Applied Sciences Group, Health Sciences Authority, Singapore.
  • Chan S; Forensic Medicine Division, Applied Sciences Group, Health Sciences Authority, Singapore.
Forensic Sci Int ; 332: 111199, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35078041
ABSTRACT
Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation's COVID vaccination program since 30 December 2020. From 1 February 2021-30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referred to the Forensic Medicine Division of the Health Sciences Authority of Singapore. Autopsies, histological sampling and ancillary investigations consisting of total tryptase level, Immunoglobulin E (IgE), and C-reactive Protein (CRP), were performed on 29 of these cases. Our study has shown no definite causative relationship between the mRNA vaccination and deaths of individuals who died within 72 h after receiving the vaccination, in particular with regards to anaphylactic reactions, myocarditis and pericarditis, and thrombotic complications. Further studies may consider increasing the incident time frame from 72 h to seven days post-vaccination or longer to include any potential delayed presentation of adverse effects.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article